索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]李超,张永红,王栋.慢性骨髓炎诊治研究进展[J].国际骨科学杂志,2024,04:224-227.
点击复制

慢性骨髓炎诊治研究进展(PDF)

《国际骨科学杂志》[ISSN:1673-7083/CN:31-1952/R]

期数:
2024年04期
页码:
224-227
栏目:
综述
出版日期:
2024-07-20

文章信息/Info

Title:
-
作者:
李超; 张永红; 王栋
030001 山西太原， 山西医科大学（李超）；030001 山西太原， 山西医科大学第二医院骨科（李超、张永红、王栋）
Author(s):
-
关键词:
慢性骨髓炎; 诊断; 治疗
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-7083.2024.04.002
文献标识码:
-
摘要:
近年来，慢性骨髓炎发病率较高，其主要发生于四肢骨，若未能及时诊断和治疗，可能造成不良后果。目前，慢性骨髓炎的研究取得许多新成果，但其诊断主要依赖于影像学检查、实验室检查和临床症状，病理学检查依然是诊断金标准。在早期诊断基础上，及时应用敏感抗生素和手术干预对于慢性骨髓炎的治疗具有重要意义。该文通过对慢性骨髓炎诊治研究进展进行综述，以期改善诊治规范性，提高慢性骨髓炎治愈率。
Abstract:
-

参考文献/References

[1] Wu ZQ, Zeng DL, Yao JL, et al. Research progress on diagnosis and treatment of chronic osteomyelitis[J]. Chin Med Sci J, 2019, 34(3):211-220.
[2] Subramanyam KN, Mundargi AV, Prabhu MV, et al. Surgical management of chronic osteomyelitis: organisms, recurrence and treatment outcome[J]. Chin J Traumatol, 2023, 26(4): 228-235.
[3] Felice JR, Herranz PG, Casado AM, et al. Chronic recurrent osteomyelitis: a diagnostic and therapeutic challenge[J]. Rev Esp Cir Ortop Traumatol, 2017, 61(1): 35-42.
[4] Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection[J]. Front Immunol, 2018, 9: 754.
[5] 李娜,林凯.六神祛腐汤外敷联合先锋霉素珠链治疗手部慢性骨髓炎疗效及对疼痛评分及血清CRP、ESR、NF-κB水平的影响[J].现代中西医结合杂志, 2019, 28(4): 417-420.
[6] Paudel R, Dogra P, Montgomery-Yates AA, et al. Procalcitonin: a promising tool or just another overhyped test?[J]. Int J Med Sci, 2020, 17(3): 332-337.
[7] Jiang N, Qin CH, Hou YL, et al. Serum TNF-α, erythrocyte sedimentation rate and IL-6 are more valuable biomarkers for assisted diagnosis of extremity chronic osteomyelitis[J]. Biomark Med, 2017, 11(8): 597-605.
[8] 叶方,黄淑明,叶积飞, 等. TNF-α与ESR和IL-6对慢性骨髓炎的诊断价值[J].中华医院感染学杂志, 2021, 31(3): 439-443.
[9] 赵文慧,徐冬祥,安仲武, 等.中性粒细胞/淋巴细胞比值、肿瘤坏死因子α和C反应蛋白对慢性骨髓炎的诊断价值[J].中国感染与化疗杂志, 2022, 22(6): 708-712.
[10] 杨全元,郭氧,穆臣会, 等.慢性骨髓炎感染病原菌及ESR、CCL11、BMP-2的诊断价值[J].中华医院感染学杂志, 2024, 34(1): 77-80.
[11] Bury DC, Rogers TS, Dickman MM. Osteomyelitis: diagnosis and treatment[J]. Am Fam Physician, 2021, 104(4): 395-402.
[12] Salman R, Mcgraw M, Naffaa L. Chronic osteomyelitis of long bones: imaging pearls and pitfalls in pediatrics[J]. Semin Ultrasound CT MR, 2022, 43(1): 88-96.
[13] Casali M, Lauri C, Altini C, et al. State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation[J]. Clin Transl Imaging, 2021, 9(4):299-339.
[14] Glaudemans AWJM, Jutte PC, Cataldo MA, et al. Consensus document for the diagnosis of peripheral bone infection in adults:a joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement)[J]. Eur J Nucl Med Mol Imaging, 2019, 46(4): 957-970.
[15] Plate A, Weichselbaumer V, Schüpbach R, et al. Diagnostic accuracy of 99mTc-antigranulocyte SPECT/CT in patients with osteomyelitis and orthopaedic device-related infections: a retrospective analysis[J]. Inter J Infect Dis, 2020, 91: 79-86.
[16] Urish KL, Cassat JE. Staphylococcus aureus osteomyelitis: bone, bugs, and surgery[J]. Infect Immun, 2020, 88(7): e00932-19.
[17] Fantoni M, Taccari F, Giovannenze F. Systemic antibiotic treatment of chronic osteomyelitis in adults[J]. Eur Rev Med Pharmacol Sci,2019, 23(2): 258-270.
[18] Wald-Dickler N, Holtom PD, Phillips MC, et al. Oral is the new IV. Challenging decades of blood and bone infection dogma: a systematic review[J]. Am J Med, 2022, 135(3): 369-379.
[19] Besal R, Adami? P, Beovi? B, et al. Systemic antimicrobial treatment of chronic osteomyelitis in adults: a narrative review[J]. Antibiotics (Basel), 2023, 12(6): 944.
[20] Samelis PV, Papagrigorakis E, Sameli E, et al. Current concepts on the application, pharmacokinetics and complications of antibiotic-loaded cement spacers in the treatment of prosthetic joint infections[J]. Cureus, 2022, 14(1): e20968.
[21] 伊力哈木·麦麦提阿卜杜拉,黄晓夏,李璐遥, 等.聚合物基抗生素缓释载体治疗慢性骨髓炎[J].中国组织工程研究, 2024, 28(22):3597-3602.
[22] Ziegenhain F, Neuhaus V, Pape HC. Bioactive glass in the treatment ofchronic osteomyelitis:a valid option?[J]. OTA Int, 2021, 4(Suppl 3):e105(1-4).
[23] 化昊天,王新卫,张磊, 等.慢性骨髓炎的诊疗研究进展[J].中国骨与关节杂志, 2022, 11(2): 132-136.
[24] 谢肇. 对骨感染控制瓶颈问题的思考[J].中华骨科杂志, 2018, 38(9): 519-522.
[25] Depypere M, Morgenstern M, Kuehl R, et al. Pathogenesis and management of fracture-related infection[J]. Clin Microbiol Infect,2020, 26(5): 572-578.
[26] 何焕弟,丁芳,李建平, 等.两种骨搬移技术对股骨慢性骨髓炎骨缺损的治疗效果[J].中华医院感染学杂志, 2023, 33(17): 2674-2677.
[27] 黄健,李坚,连霄, 等. Masquelet技术治疗胫骨慢性骨髓炎合并骨缺损的疗效分析[J]. 中华全科医学, 2022, 20(10): 1682-1684.
[28] 芮菲,卜凡玉,张樱严, 等. Masquelet技术治疗骨缺损时体内制作与体外制作骨水泥间隔的疗效比较[J]. 中华创伤骨科杂志, 2021, 23(8): 674-680.
[29] Liu K, Shi L, Liu Y, et al. Ilizarov bone transport versus Masquelet technique for the treatment of bone defects caused by infection: a meta-analysis[J]. Asian J Surg, 2023, 46(12): 6109-6111.
[30] Goerger E, Honnorat E, Savini H, et al. Anti-infective therapy without antimicrobials: apparent successful treatment of multidrug resistant osteomyelitis with hyperbaric oxygen therapy[J]. IDCases, 2016, 6:60-64.
[31] Chen J, Wang X, Li J, et al. Research status and hotspots of chronic osteomyelitis: a bibliometric and visualized analysis[J]. Orthop Surg, 2022, 14(12): 3378-3389.

备注/Memo

备注/Memo:
基金项目： 国家自然科学基金（82172439）
通信作者： 张永红 E-mail ： yhzhy@139.com
更新日期/Last Update: 2024-07-20